Chemours (CC) Receivables (2014 - 2026)

Chemours' Receivables history runs 13 years deep, the most recent figure standing at $782.0 million for Q1 2026.

• On a quarterly basis, Receivables fell 12.04% year-over-year to $782.0 million in Q1 2026; TTM through Mar 2026 was $782.0 million, a 12.04% decrease from a year earlier, with the FY2025 full-year figure at $583.0 million, down 27.76% from the prior year.
• Receivables grew to $782.0 million in Q1 2026 per CC's latest filing, from $583.0 million in the prior quarter.
• Across five years, Receivables topped out at $1.2 billion in Q2 2022 and bottomed at $583.0 million in Q4 2025.
• The 5-year median for Receivables is $867.0 million (2023), against an average of $874.5 million.
• Across the five-year window, Receivables surged 56.02% in 2022 and sank 30.79% in 2023, its largest moves.
• Year by year, Receivables stood at $655.0 million in 2022, then slipped by 1.98% to $642.0 million in 2023, then rose by 25.7% to $807.0 million in 2024, then retreated by 27.76% to $583.0 million in 2025, then jumped by 34.13% to $782.0 million in 2026.
• Per Business Quant, the three latest CC Receivables figures stand at $782.0 million (Q1 2026), $583.0 million (Q4 2025), and $975.0 million (Q3 2025).